Ronald A. Pepin's Insider Trades & SAST Disclosures

Ronald A. Pepin's most recent trade in Celldex Therapeutics Inc. was a trade of 20,000 Incentive Stock Option (right to buy) done . Disclosure was reported to the exchange on June 13, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Celldex Therapeutics Inc.
Ronald A. Pepin SR. VP & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 20,000 20,000 - - Incentive Stock Option (right to buy)
Celldex Therapeutics Inc.
Ronald A. Pepin SR. VP & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 15,000 15,000 - - Incentive Stock Option (right to buy)
Celldex Therapeutics Inc.
Ronald A. Pepin SR. VP & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 15,000 15,000 - - Incentive Stock Option (right to buy)
Celldex Therapeutics Inc.
Ronald A. Pepin Sr. VP & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 15,500 15,500 - - Incentive Stock Option (right to buy)
Celldex Therapeutics Inc.
Ronald A. Pepin Sr. VP & CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 14,400 14,400 - - Incentive Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades